Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.
News|Articles|September 23, 2026
FAQ: How should pediatricians hand off teens with diabetes?
Author(s)Contemporary Pediatrics Staff
Fact checked by: Morgan Ebert, Executive Editor
ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.
Advertisement
Advertisement
The International Society for Pediatric and Adolescent Diabetes (ISPAD), the European Association for the Study of Diabetes (EASD), and the American Diabetes Association (ADA) have released a joint consensus report on the transition of adolescents and young adults with diabetes from pediatric to adult diabetes care. The report is being published simultaneously in Diabetologia, Hormone Research in Paediatrics, and Diabetes Care, and it was approved by the boards of all 3 organizations.
Related to this article
At AAP 2026, Stephen Bondi, JD, MD, FAAP, outlined steps pediatricians should take after receiving notice of a malpractice claim.
Stephen Bondi, JD, MD, FAAP, discusses pediatric malpractice risks and the importance of relationships and communication when adverse events occur.
Brittany S. Bruggeman, MD, reviews teplizumab (Tzield), islet autoantibody screening, and automated insulin delivery, and how pediatricians can help families.
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Real-world claims show dupilumab was tied to a 33%-52% lower risk of atopic march progression vs systemic corticosteroids in children with AD.
Once-daily roflumilast cream 0.05% was well tolerated in infants 3 to <24 months with AD, with 34.4% reaching vIGA-AD success at week 4.
Oral icotrokinra kept PASI 90 rates at ≥72% and IGA 0/1 at ≥70% from week 64 to 112 in ICONIC-LEAD, with no new safety signals.
Advertisement
Advertisement